Spanish Red Biotech Pipeline
< Back
Drugs: Multinational Subsidiaries
Home
Toggle navigation
Pipeline
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
RESEARCH PLATFORMS
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Search
Charts
DRUGS: MULTINATIONAL SUBSIDIARIES
DRUGS: NATIONAL COMPANIES
DIAGNOSTICS AND PERSONALIZED MEDICINE
OTHER TECHNOLOGIES
Green pipeline
White pipeline
Spanish Red Biotech Pipeline
/
Pipeline
/
Drugs: Multinational Subsidiaries
MSD
Pembrolizumab
Type:
Biodrugs/ Drugs
Therapeutic area:
Cancer
Indication:
Pembrolizumab Plus Enzalutamide versus Placebo Plus Enzalutamide in Participants with metastatic Castration-Resistant Prostate Cancer
Phase:
3
Phase III in Spain
,
2
Phase II
,
1
Phase I